Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 31, 2002

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

mafosfamide

Trial Locations (9)

48202

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit

55905

Mayo Clinic Cancer Center, Rochester

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

20010-2970

Children's National Medical Center, Washington D.C.

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

77030-2399

Texas Children's Cancer Center, Houston

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

05201

Neurological Research Center, Inc., Bennington

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00031928 - Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors | Biotech Hunter | Biotech Hunter